ZJKC Unveils Advanced rTMS Apparatus: Non-Invasive Neurological Therapy for Home and Clinical Use

The ZJKC Repetitive Transcranial Magnetic Stimulation Apparatus combines rTMS with low-frequency therapy, offering non-invasive treatment for neurological disorders, mental health issues, and more—now accessible for home use with personalized, efficient care. End Quote

(1888PressRelease) July 23, 2025 - Wuhan Zhongjie Kechuang Technology Co., Ltd. introduces the ZJKC Repetitive Transcranial Magnetic Stimulation (rTMS) Apparatus, a groundbreaking device revolutionizing neurological and mental health care. This advanced system merges repetitive transcranial magnetic stimulation with low-frequency alternating electromagnetic therapy, providing a non-invasive solution for diverse conditions.

Designed for both clinical and home use, the device delivers targeted magnetic pulses to specific brain regions, modulating neural activity to support recovery. High-frequency stimulation (≥10 Hz) enhances cortical excitability, while low-frequency (1 Hz) calms overactive neurons, adapting to individual needs through repeated sessions that foster neuroplasticity.

Its applications span neurodegenerative diseases (Alzheimer’s, Parkinson’s), post-stroke rehabilitation, mental health disorders (depression, anxiety), chronic pain management, cognitive enhancement, and sleep regulation. For patients, this means convenient, consistent therapy outside clinics; for clinicians, pre-programmed modes and intuitive controls streamline workflows.

With personalized options—multiple heads and frequency modes—and a focus on comfort, the ZJKC rTMS Apparatus redefines accessible care, offering hope for treatment-resistant conditions. It bridges professional and at-home therapy, marking a significant step forward in patient-centered neuroscience.

###

space

Other Related Press Releases